BioCryst Pharmaceuticals, Inc. (FRA:BO1)
Germany · Delayed Price · Currency is EUR 6.10
+0.13 (2.18%)
At close: Dec 19, 2025
BioCryst Pharmaceuticals Market Cap
BioCryst Pharmaceuticals has a market cap or net worth of €1.33 billion as of December 19, 2025. Its market cap has decreased by -7.65% in one year.
Market Cap
1.33B
Enterprise Value
1.73B
Revenue
511.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.10
Market Cap Chart
Since March 4, 1994, BioCryst Pharmaceuticals's market cap has increased from 19.07M to 1.33B, an increase of 6,880.35%. That is a compound annual growth rate of 14.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 1.33B | -11.51% |
| Dec 31, 2024 | 1.50B | 35.56% |
| Dec 29, 2023 | 1.11B | -44.58% |
| Dec 30, 2022 | 2.00B | -8.62% |
| Dec 31, 2021 | 2.19B | 103.78% |
| Dec 31, 2020 | 1.08B | 127.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 130.23B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |